Clinical trial
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABSK061 Minitablets Following Single and Multiple Oral Doses and to Assess the Effect of Administration With Soft Foods in Healthy Adults
NCT06306872 is registered in ClinicalTrials.gov with Abbisko Therapeutics Co, Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABSK061 Minitablets Following Single and Multiple Oral Doses and to Assess the Effect of Administration With Soft Foods in Healthy Adults
- Lead sponsor
- Abbisko Therapeutics Co, Ltd
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 23, 2024
- Completion date
- September 30, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects